TrialJournal of nuclear medicine : official publication, Society of Nuclear Medicine2021

Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial.

Marie Øbro Fosbøl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.